Masseter Botox (Jaw Botox) in Australia: Cost, Dosage and Does It Work?

Masseter Botox gets searched for two completely different reasons, and most articles online blur them together. Some people want a narrower, more V-shaped lower face by shrinking an overdeveloped jaw muscle. Others are chasing relief from grinding, clenching and jaw pain that keeps them up at night or gives them tension headaches. It is the same injection, into the same muscle, but the honest evidence behind each goal is genuinely different, and this guide covers both properly rather than picking one.

Masseter Botox in Australia typically costs $350 to $1,500 per session, priced as a flat treatment fee rather than strictly per unit, with most people needing 20 to 60 units per side depending on muscle size and ethnicity. Results are not immediate: visible slimming starts around two weeks in and peaks around three months, because it works through gradual muscle shrinkage, not just wrinkle relaxation. For jaw pain and teeth grinding specifically, the peer-reviewed evidence is more mixed than most clinic marketing suggests, and this guide reports that honestly rather than overselling it.

What masseter Botox actually is

The masseter is one of the main muscles used for chewing, a thick, paired muscle running from the cheekbone down to the jawbone on each side of the face. A peer-reviewed clinical journal describes it plainly: it is “the most powerful” of the four chewing muscles, and it is “quadrangular in shape,” running from the zygomatic arch down to the jawbone, allowing the jaw to close with real force. When this muscle is unusually large, the clinical term is masseteric hypertrophy, sometimes called benign masseteric hypertrophy or idiopathic masseteric hypertrophy in the literature, first described by a researcher named Legg back in 1880.

Why does the muscle get bigger in the first place? A peer-reviewed case report notes it is “set particularly by the biting force, chewing habits, type of food, diet, or para-functional habits like bruxism,” though the same literature is candid that in most individual cases the exact cause is genuinely unclear, not always linked to grinding or clenching the way people assume. Jaw and chin shape are often assessed together for this reason, and our chin filler guide covers the volume-adding side of lower-face contouring in full. A widely cited clinical classification, from Kwon and colleagues, splits enlarged jaws into three types: Type I, where the bulk is genuinely from an overgrown muscle, Type II, where a naturally prominent jawbone angle is the real cause rather than the muscle, and Type III, a combination of both. This distinction matters, because Botox only meaningfully helps Type I, and possibly Type III, while a purely bony Type II jaw will not shrink no matter how much toxin is injected.

Two different reasons people get this treatment

The injection itself does not change based on why you are getting it, but the goal, and how confident the evidence is behind that goal, genuinely differs.

Cosmetic jaw slimming. The masseter is injected to reduce its bulk, softening a square or wide lower face into a narrower, more tapered shape. A peer-reviewed literature review frames this and the therapeutic use as genuinely overlapping outcomes of the same treatment, noting the injection “decreases muscle bulk and reshapes the lower face” while also improving “pain and symptoms of grinding and clenching.”

Bruxism and TMJ jaw pain. The same injection is used to reduce the force of habitual teeth grinding and clenching, and to ease jaw tension, jaw joint pain and the headaches that often come with it. Clinical use for this purpose has been documented since the year 2000, when early research first suggested botulinum toxin as “a safe and effective treatment for people suffering from severe bruxism, reducing muscular activity.”

How much masseter Botox costs in Australia

No government body publishes official pricing, since masseter Botox is not a Medicare-rebatable item, so every figure below comes from surveying current Australian clinic pricing. Unlike glabellar Botox, which is usually priced strictly per unit, many Australian clinics price masseter treatment as a flat session fee, since the total unit count and therefore the per-unit maths varies so much between patients.

How many units are actually used

Dosing for masseter Botox is not standardised the way glabellar dosing is, and the peer-reviewed literature is candid about this. A published systematic review of masseter injection studies explicitly notes there is high variation in the injection protocols used across the published research, with no single agreed standard.

That said, a clear consensus range does exist. A peer-reviewed clinical journal, aggregating five separate published studies, states: “literature shows evidence of effectiveness from using 20 to 30 units of Onabotulinum toxin on each side in Western patients to 40 to 60 units in Asian patients on each side.” A published case report using a six-point injection technique across the muscle used 30 units on one side and 36 units on the other, adjusted for the fact that one side was visibly larger than the other, a reminder that dosing is tailored to your actual anatomy rather than applied as a flat number.

Interestingly, the dose often goes down over repeat treatments, not up. One documented case example showed a patient’s dose reduced from 50 units to 35 units, then to 25 units per side, across three sessions over a year, as the muscle progressively lost bulk and needed less toxin to maintain the same slimmer result.

Masseter Botox cost estimator

This tool gives a rough estimate only, based on the typical dosing ranges and Australian clinic pricing set out above. It is not a quote, and your actual treatment plan can only be confirmed at a real consultation.

Why masseter Botox takes longer to work than other areas

If you have had Botox for frown lines before, you might expect to see a result within a few days. Masseter Botox works differently, and slower, because slimming the jaw relies on genuine muscle shrinkage, not just relaxing a muscle that causes a wrinkle. A peer-reviewed clinical journal explains the distinction directly: the muscle-shrinking effect is “secondary to relaxation,” meaning the toxin first stops the muscle contracting with full force, and only afterward, as the muscle goes comparatively unused, does it gradually lose bulk through disuse, the same way any muscle shrinks when it stops being exercised hard.

The clearest published timeline comes from two cited clinical studies: visible facial changes were noticed “as early as two weeks after injections,” with the effect reaching its strongest, statistically significant point at three months, before gradually declining by six months. Commercial clinic sources describe a similar, more granular breakdown, tension relief in the first one to two weeks, visible slimming from around weeks two to four, and the most noticeable contour change by weeks four to eight, broadly lining up with the peer-reviewed two-week-to-three-month timeline even though the finer week-by-week detail itself comes from clinic marketing rather than a published study.

How long the results last

Published research generally puts the therapeutic effect at three to six months, modestly longer than the roughly three to four months typical of glabellar Botox, though no single study has directly compared the two areas head to head in the same patients, so treat this as a reasonable, well-supported estimate rather than an exact figure. A documented case report found the masseter’s actual muscle bulk stayed measurably reduced, by 15 to 25 percent, at the six-month follow-up mark after just one treatment session.

Risks and side effects, explained properly

The best available complication data comes from a large peer-reviewed review of 2,036 treatment sessions across 680 patients over six years, which is a genuinely useful, real-world dataset rather than a small trial. It found the single most common effect was a temporary decrease in chewing strength and mild pain, in 30 percent of treatments, though this typically improved within a week. Bruising followed at 2.5 percent, headaches at 0.58 percent, an unwanted bulging or lumpy appearance at 0.49 percent, sunken cheeks at 0.44 percent, sagging at 0.20 percent, and a limited or asymmetric smile at 0.15 percent.

Asymmetric or crooked smile

This is the complication most specific to this area, and it is well documented. The muscles used for smiling, the zygomaticus and risorius, sit close to the upper masseter, and if toxin diffuses into them, it can genuinely change how your smile looks, not just your jawline. The same large review attributes this to “injections into the zygomatic muscles causing subzygomatic volume loss, change in smiling expression by toxin diffusion into the risorius muscle.” A separate peer-reviewed anatomical study exists purely to help injectors map the risorius muscle precisely, specifically to help prevent this exact complication, which tells you it is a recognised, real risk that experienced injectors actively plan around, not a rare fluke.

Compensatory hypertrophy: a real, underused fact

This is genuinely underreported outside clinical literature, and worth knowing before you commit to repeat treatment. When the lower masseter is weakened by Botox, some of the chewing workload can shift to nearby muscles that were not injected. Peer-reviewed research has documented two versions of this: the upper, deeper part of the masseter itself can become compensatorily hypertrophied after long-term repeated treatment, and separately, the temporalis muscle, at the side of the head above the ear, can measurably enlarge and stiffen as it takes over some of the force the masseter used to provide. One study’s own conclusion states plainly that clinicians should plan additional injections “in consideration of the anatomical structure, in case of an unexpected result due to long-term treatment,” precisely because of this compensatory pattern.

Does it actually work for jaw pain and teeth grinding?

This is the single most important thing many clinic websites will not tell you honestly: the peer-reviewed evidence for treating jaw pain and bruxism with Botox is genuinely mixed, with two credible, recent reviews reaching opposite headline conclusions.

On one side, a 2024 systematic review reported dramatic results from individual included studies: pain scores dropping from an average of 7.1 down to 0.2 at six months and one year in one study, described as pain reduction “of up to 91 percent,” and bruxism episodes falling from around five per hour to under two per hour in another, described as reductions “of up to 87 percent.” These numbers sound compelling, but the reviewers themselves added an important caveat, stating the findings were “preliminary due to variability in study designs and the absence of detailed statistical analysis,” and that the differences between the included studies were too great to even combine the results into a formal statistical analysis.

On the other side, a separate and more methodologically rigorous 2024 meta-analysis, published in the peer-reviewed journal PLOS ONE, pooled 14 randomised controlled trials covering 395 patients and reached a considerably more cautious conclusion. Its stated result: “BTX treatment was not significantly better than placebo for a reduction in pain scores at 1, 3, and 6 months.” The same analysis found “no difference in the effectiveness of BTX compared to placebo and other treatments for maximum mouth opening, bruxism events, and maximum occlusal force,” and concluded plainly that “more high-quality RCTs are needed to better understand this topic.” This lines up with an earlier Cochrane-affiliated review, which similarly found no conclusive evidence that Botox improves this type of jaw pain.

Worth understanding too: even where Botox does help, it manages a symptom rather than curing a cause. A placebo-controlled trial using sleep-lab monitoring found Botox reduced the intensity of muscle contractions during grinding for at least twelve weeks, but the study’s own conclusion was clear that it “could not control the genesis,” meaning the underlying neurological drive to grind did not go away, only the force behind it was dampened.

Masseter Botox versus buccal fat removal versus jaw filler

People chasing a narrower lower face often land on masseter Botox without realising it is only one of three genuinely different treatments that get discussed for this goal, each working on a different tissue entirely.

Which one is right for you depends entirely on what is actually driving the appearance of your jaw. If it is muscle bulk from clenching or grinding, Botox is the logical choice. If it is fullness in the mid to lower cheek rather than the jaw itself, buccal fat removal targets a different area entirely and will not address a genuinely wide jaw. And if your jaw actually needs more definition or symmetry rather than reduction, dermal filler solves the opposite problem. A practitioner recommending one of these without properly assessing which tissue is actually responsible for your concern is worth a second opinion.

Who is a good candidate, and who should think twice

Good candidates typically have masseter bulk you can see or feel getting harder when you clench your teeth, ongoing jaw tension or pain, regular night-time grinding, or a square lower face driven by muscle rather than bone. This lines up with the muscle-driven category described earlier; if your jaw width is genuinely coming from a naturally prominent jawbone rather than an overgrown muscle, Botox will not meaningfully change your shape, and that should be identified before you pay for treatment, not after.

A few groups deserve extra caution. If you already have a naturally thin or narrow face, further muscle reduction can tip into looking gaunt rather than contoured, since the treatment genuinely shrinks tissue rather than simply relaxing it. People with existing looseness in the lower face and jawline may notice slightly more sagging once the muscle beneath the skin loses some of its supportive bulk. And while not something we can confirm from a specific study, it is a reasonable, common-sense caution: if your work or lifestyle genuinely depends on strong, sustained bite force, remember that around 30 percent of people experience some temporary chewing weakness after treatment, usually resolving within a week, which is worth planning around rather than being surprised by. The same general Botox contraindications covered in our Botox cost guide, including pregnancy, breastfeeding and certain neuromuscular conditions, apply here too.

Who can legally give you masseter Botox in Australia

The same rules covered in our Botox cost guide apply here. Botox is a Schedule 4 prescription medicine, legally prescribed only by a registered medical practitioner, dentist or nurse practitioner, and administered by a registered or enrolled nurse under that prescription. Given that masseter work sits close to nerves controlling your smile and involves genuinely variable, technique-dependent dosing, experience specifically with this area matters more here than for most other Botox treatments.

Is masseter Botox right for you?

• You have visible or palpable jaw muscle bulk that gets noticeably harder when you clench, not a naturally wide jawbone.
• You are comfortable waiting several weeks to see the full slimming effect, since this treatment works through gradual muscle shrinkage rather than an instant change.
• If you are treating jaw pain or grinding specifically, you understand the evidence is genuinely mixed and are going in with realistic expectations, not a guarantee.
• You are prepared for temporary chewing weakness in the days after treatment, which affects around three in ten people and usually resolves within a week.
• You are booking with an AHPRA-registered practitioner experienced specifically with masseter injections, given the nearby smile-related muscles this area requires care around.
• You have budgeted for the real ongoing cost, roughly every three to six months initially, even though the dose and cost may reduce over repeated sessions.

Questions worth asking before you book

1. Are you AHPRA-registered, and can I see your registration details?
2. Do you think my jaw width is coming from muscle, bone, or both, and how did you assess that?
3. How many units do you plan to use per side, and what is the total session cost?
4. How many years of experience do you have specifically with masseter injections?
5. If I am treating jaw pain or grinding, what result should I realistically expect, and by when?
6. What is your plan if I notice a change in my smile after treatment?

Masseter Botox, done properly, is a genuinely well-understood treatment for slimming a muscle-driven wide jaw, with a clear evidence base behind the mechanism and dosing. For jaw pain and teeth grinding specifically, treat confident marketing claims with healthy scepticism, since the strongest pooled clinical evidence has not settled the question. Either way, choose your practitioner on genuine experience with this specific area, not on whoever quotes the lowest session price.

Frequently asked questions